94 results
Page 4 of 5
6-K
EX-99.1
c152 cyfw
4 Apr 22
European Commission Approves KIMMTRAK® (tebentafusp) for the treatment of unresectable or metastatic uveal melanoma
4:06pm
6-K
EX-99.1
qkkuq 9wer42dvwog
3 Mar 22
Immunocore Reports Full Year 2021 Financial Results
7:01am
6-K
EX-99.2
s3zs3llj0v8iit zqjs
3 Mar 22
Immunocore Reports Full Year 2021 Financial Results
7:01am
6-K
EX-99.1
4rhz3pu
26 Jan 22
Immunocore announces FDA approval of KIMMTRAK® (tebentafusp-tebn) for the treatment of unresectable or metastatic uveal melanoma
4:29pm
6-K
EX-99.1
qwtj2kz78nx
7 Dec 21
Immunocore announces initial Phase 1 data of ImmTAC® candidate IMC-C103C targeting MAGE-A4
4:10pm
6-K
EX-99.2
ra7rob
10 Nov 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:01am
6-K
EX-99.1
iksihgwc
10 Nov 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:01am
6-K
EX-99.3
qp4 sa4pv8s
10 Nov 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:01am
6-K
EX-99.1
oqmdsgnmotb
11 Aug 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:00am
6-K
EX-99.2
aiwv 42enfb8gh
11 Aug 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:00am
6-K
EX-99.3
8vpuvpyqvk
11 Aug 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:00am
6-K
EX-99.2
7cg iab3v
12 May 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:00am
6-K
EX-99.3
5p23wue
12 May 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:00am
6-K
EX-99.1
v69pztgdtus2 jlvfr
12 May 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:00am
20-F
ht9ysyl0cftc3s hwpv
25 Mar 21
Annual report (foreign)
7:01am
424B4
a9bip2
8 Feb 21
Prospectus supplement with pricing info
8:36am
F-1/A
j4knq4
3 Feb 21
Registration statement (foreign) (amended)
5:22pm
F-1/A
wldkpl
1 Feb 21
Registration statement (foreign) (amended)
6:21am
F-1/A
EX-99.1
u40q h6l7
1 Feb 21
Registration statement (foreign) (amended)
6:21am